To assess lipid screening rates and the prevalence of dyslipidemia among children with congenital heart defects (CHD).
Approach:
Study Design: A retrospective electronic medical record study was conducted on children with CHD aged 9 to 18 years at Nationwide Children’s Hospital from 2012 to 2019.
Data Collection: Demographic information, vital signs, and lipid panels were collected from clinical encounters, focusing on those who underwent echocardiograms.
Classification: Patients were categorized into screened and unscreened groups based on lipid panel availability, and further into normolipidemic and dyslipidemic based on lipid criteria.
Key Findings:
Only 18-31% of children with CHD underwent lipid screening based on cardiac diagnosis.
Dyslipidemia rates varied significantly among different types of CHD.
Childhood lipid values can predict adult lipid levels.
Interpretation:
The study highlights low adherence to lipid screening guidelines in children with CHD and the need for improved identification of dyslipidemia in this population.
Limitations:
The study was retrospective and relied on existing medical records.
Fasting status for lipid panels was unknown, which may affect triglyceride and LDL-C levels.
Conclusion:
Understanding lipid screening and dyslipidemia in children with CHD is crucial for improving cardiovascular health outcomes.
Investigators linked distinct odor patterns to life stage, sex, and skin microbes, while limited longitudinal evidence leaves their clinical utility uncertain.
